Medications

FDA: Samsca may cause irreversible liver damage

(HealthDay)—Patients who take Samsca (tolvaptan) may be at elevated risk for significant liver injury, according to a Jan. 25 safety alert issued by the U.S. Food and Drug Administration.

Medications

FDA approves juxtapid for rare cholesterol disorder

(HealthDay)—The U.S. Food and Drug Administration has approved the orphan drug Juxtapid (lomitapide) for patients with homozygous familial hypercholesterolemia (HoFH), for use in combination with a low-fat diet and other ...

Diseases, Conditions, Syndromes

Hep C cases linked to NH hospital worker rise

(AP)—Five more people have been diagnosed with the same strain of hepatitis C a former traveling hospital worker is accused of spreading through tainted needles. The total is now 44 in four states.

Diseases, Conditions, Syndromes

One man's harrowing battle with hepatitis C

(HealthDay)—Ted Adamson's liver had been so ravaged by the hepatitis C virus that he was nearly at the point of needing a liver transplant. Yet he had no symptoms. None. He didn't even feel tired.

Health

Study shows BPA exposure in fetal livers

New research from the University of Michigan School of Public Health found BPA, or bisphenol A, in fetal liver tissue, demonstrating that there is considerable exposure to the chemical during pregnancy.

page 34 from 40